Board of Directors
William Garner, MD
Chairman of the Board of Director
Dr. Garner is the founder of EGB Ventures, where he has focused on advancing technologies and companies to significant value inflection points, leading to monetization of assets via licensing, mergers and acquisitions or IPO transactions.
Martin Bott, MIBS
Mr. Bott has over 30 years of experience in senior financial and executive leadership. He currently serves as VP Finance, Special Projects at Eli Lilly & Company. He joined Lilly in 1988 and has held roles of increasing responsibility at their headquarters in Indianapolis
Mr. Cutler has over 20 years of experience in the global healthcare industry where he successfully held senior leadership positions in various roles from Equity Research, Corporate Affairs and Strategy, Investor Relations and Consulting.
Andrew Hull, BA
Mr. Hull has over 30 years’ experience in various commercial and business development roles with leading pharmaceutical and biotech companies. He most recently served as Vice President of Global Alliances for Takeda Pharmaceuticals where he was responsible
Eric A. Adams, MIBS
Chief Executive Officer & President
Mr. Adams is a seasoned biopharmaceutical executive with over 30 years’ experience in company and capital formation, global market development, mergers and acquisitions, licensing and corporate governance.
Catherine A. Sazdanoff, JD
Ms. Sazdanoff is a 35-year veteran of the global pharmaceutical industry and currently serves as President and CEO of Sazdanoff Consulting LLC, which she founded in 2014, where she works with healthcare companies on strategy and corporate development.